<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03713541</url>
  </required_header>
  <id_info>
    <org_study_id>LO 766/16-1m; GU 156</org_study_id>
    <nct_id>NCT03713541</nct_id>
  </id_info>
  <brief_title>Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation</brief_title>
  <acronym>FABIANA</acronym>
  <official_title>Identification of Beneficial and Inhibitory Factors for Treatment in Patients With Anorexia Nervosa: A Pathway to Effective Secondary Prevention and Prognostic Improvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia nervosa (AN) is a comparably low-prevalent illness. Chronic courses are often and&#xD;
      the mortality rate of patients with AN is higher than in any other mental illness. A major&#xD;
      influence on the course of the illness is the interval between the onset of AN symptoms and&#xD;
      the beginning of an adequate treatment (duration of untreated illness, DUI). Patients with AN&#xD;
      have a better prognosis if treated early. Previous large-scale interventions have not shown&#xD;
      the desired positive effects on the DUI. Therefore, an important starting point seems to be a&#xD;
      better initial understanding of the factors influencing the DUI, which is the major aim of&#xD;
      this project.&#xD;
&#xD;
      The planned mixed-method study is divided in three consecutive sub-studies. The first&#xD;
      substudy aims to identify modifiable factors influencing the DUI using semi-structured&#xD;
      interviews and a multi-informant approach (patients, carers, physicians). As a result of this&#xD;
      qualitative analyses using Grounded Theory the most relevant factors will be determined. The&#xD;
      motivation of the second substudy is to condense the factors identified to influence the DUI&#xD;
      into a checklist and to conduct a first psychometric evaluation of this newly developed&#xD;
      instrument. The third substudy aims to quantitatively determine the magnitude of the effects&#xD;
      of a) a priori determined non-modifiable factors and b) the modifiable checklist-factors&#xD;
      using a multi-informant approach (planned n for each informant = 130; 13 co-operating&#xD;
      specialized clinics and 6 cooperating outpatient partners). Additional outpatient partners&#xD;
      may be recruited during the course of the study.&#xD;
&#xD;
      In conclusion, the study aims to derive recommendations for effective secondary prevention.&#xD;
      Thereby, the study might ultimately contribute to earlier treatment initiation of patients&#xD;
      with AN, and to the prevention of chronic courses and the associated high health care costs&#xD;
      and individual burden.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anorexia nervosa (AN) is a comparably low-prevalent, yet due to its somatic and mental&#xD;
      consequences serious illness. Chronic courses are often and the mortality rate of patients&#xD;
      with AN is higher than in any other mental illness.&#xD;
&#xD;
      A major influence on the course of the illness is the interval between the onset of AN&#xD;
      symptoms and the beginning of an adequate treatment (duration of untreated illness, DUI).&#xD;
      That is, patients with AN have a better prognosis if treated early. Previous large-scale&#xD;
      interventions have not shown the desired positive effects on the DUI. Therefore, an important&#xD;
      starting point seems to be a better initial understanding of the factors influencing the DUI,&#xD;
      which is the major aim of this project. Based on this evidence, this study aims to derive&#xD;
      recommendations for effective secondary prevention.&#xD;
&#xD;
      To our very best knowledge this is the first study investigating factors influencing the DUI&#xD;
      using a multi-informant strategy, that is exploring the perspective of patients with AN,&#xD;
      their significant carers and involved physicians. Furthermore, the study will avoid the&#xD;
      confounding of patients with different eating disorder diagnoses, i.e. it will include&#xD;
      exclusively patients with AN. Finally, there will be a clear focus on factors which are&#xD;
      modifiable and precise in their definition.&#xD;
&#xD;
      The planned mixed-method study is divided in three consecutive sub-studies. The first&#xD;
      substudy aims to identify modifiable factors influencing the DUI using semi-structured&#xD;
      interviews and a multi-informant approach (patients, carers, physicians). As a result of this&#xD;
      qualitative analyses using Grounded Theory the most relevant factors will be determined. The&#xD;
      motivation of the second substudy is to condense the factors identified to influence the DUI&#xD;
      into a checklist and to conduct a first psychometric evaluation of this newly developed&#xD;
      instrument. The third substudy aims to quantitatively determine the magnitude of the effects&#xD;
      of a) a priori determined non-modifiable factors and b) the modifiable checklist-factors&#xD;
      using a multi-informant approach (planned n for each informant = 130; 13 co-operating&#xD;
      specialized clinics and 6 cooperating outpatient partners). Additional outpatient partners&#xD;
      may be recruited during the course of the study.&#xD;
&#xD;
      In conclusion, the study aims to derive recommendations for effective secondary prevention.&#xD;
      Thereby, the study might ultimately contribute to earlier treatment initiation of patients&#xD;
      with AN, and to the prevention of chronic courses and the associated high health care costs&#xD;
      and individual burden.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of untreated illness (DUI in months)</measure>
    <time_frame>from date of study enrolment up to 12 weeks</time_frame>
    <description>DUI (defined as the time between occurence of first symptoms and treatment) is assessed retrospectively and cross-sectional using standardized interviews and paper-and-pencil questionnaires.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of first contact (DUC in month)</measure>
    <time_frame>from date of study enrolment up to 12 weeks</time_frame>
    <description>DUC is assessed cross-sectional (retrospectively) using standardized interviews and paper-and-pencil questionnaires.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Feeding and Eating Disorders of Childhood</condition>
  <arm_group>
    <arm_group_label>Patients with Anorexia nervosa (AN)</arm_group_label>
    <description>Female patients with Anorexia nervosa (AN, ICD-10: F50.0/1) of 14 years and older, receiving an initial treatment due to their AN (start of initial treatment no longer than 3 months ago, inpatient care: at least 7 days inpatient; outpatient care: at least 5 sessions with the same therapist) with sufficient language skills and no serious organic or psychiatric illnesses and no acute suicidality will be consecutively included in the study. No intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carers of patients with AN</arm_group_label>
    <description>Significant caregivers in AN patients aged 14 to 15 years: parents; in AN patients aged 16 years and over: parents or other significant carer. No intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physicians of patients with AN</arm_group_label>
    <description>Resident general practitioner, pediatrician, internist or gynecologist with at least one medical patient contact within the last 12 months. No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Survey during normal supply.</description>
    <arm_group_label>Carers of patients with AN</arm_group_label>
    <arm_group_label>Patients with Anorexia nervosa (AN)</arm_group_label>
    <arm_group_label>Physicians of patients with AN</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with AN will be recruited from n=13 inpatient clinics with special treatment&#xD;
        units/specialized inpatient units and n=6 outpatient psychotherapists specialized for&#xD;
        eating disorders.&#xD;
&#xD;
        Additional outpatient partner may be recruited during the course of the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        AN patients&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
          -  Female patients, 14 years and older&#xD;
&#xD;
          -  Treatment diagnosis anorexia nervosa (ICD-10: F50.0/1)&#xD;
&#xD;
          -  Initial treatment (start of initial treatment no longer than 3 months ago)&#xD;
&#xD;
          -  Inpatient care: at least 7 days inpatient&#xD;
&#xD;
          -  Outpatient care: at least 5 sessions with the same therapist&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Insufficient language skills&#xD;
&#xD;
          -  Serious organic or psychiatric illnesses&#xD;
&#xD;
          -  Acute suicidality&#xD;
&#xD;
        Significant caregiver&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
          -  in AN patients aged 14 to 15 years: parents ; in AN patients aged 16 years and over:&#xD;
             parents or other significant carer&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Consent of the patient&#xD;
&#xD;
        Exclusion criteria - Insufficient language skills&#xD;
&#xD;
        Physician&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
          -  Resident general practitioner, pediatrician, internist or gynecologist&#xD;
&#xD;
          -  At least one medical patient contact within the last 12 months&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Consent of the patient and release from confidentiality&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
        - Insufficient language skills&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antje Gumz, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernd Loewe, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angelika Weigel, Dr.</last_name>
    <phone>+4915222827125</phone>
    <email>a.weigel@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence Reuter, Dr.</last_name>
    <phone>+4915222815684</phone>
    <email>l.reuter@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Schön Clinic Roseneck</name>
      <address>
        <city>Prien am Chiemsee</city>
        <state>Bavaria</state>
        <zip>83209</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Voderholzer, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schön Clinic Bad Bramstedt</name>
      <address>
        <city>Bad Bramstedt</city>
        <state>Schleswig-Holstein</state>
        <zip>24576</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Osen, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Curtius-Clinic, Specialist Clinic for Psychosomatics and Psychotherapeutic Medicine</name>
      <address>
        <city>Bad Malente</city>
        <state>Schleswig-Holstein</state>
        <zip>23714</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Kleinschmidt, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schön Clinic Bad Arolsen</name>
      <address>
        <city>Bad Arolsen</city>
        <zip>34454</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M Seidel, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Lüneburger Heide</name>
      <address>
        <city>Bad Bevensen</city>
        <zip>29549</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W Wünsch-Leiteritz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MediClin Seepark Clinic</name>
      <address>
        <city>Bad Bodenteich</city>
        <zip>29389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Schwennen, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Timmermann &amp; Partner, Medical care center for physical and mental health</name>
      <address>
        <city>Cuxhaven</city>
        <zip>27472</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S Rieper</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Child and Adolescent Psychiatry of the University Medical Center Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Local psychotherapists</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Behavior therapy Falkenried MVZ GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiki Peter</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>VT Falkenried Training and Education</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roman Wessels</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Psychosomatic Medicine and Psychotherapy, Asklepios West Clinic Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20559</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Fehrs, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schön Clinic Eilbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Albrecht, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schön Clinic Hamburg Eilbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Albrecht, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Behavior Therapy Education Hamburg (IVAH)</name>
      <address>
        <city>Hamburg</city>
        <zip>22085</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Asklepios Clinic Nord - Ochsenzoll</name>
      <address>
        <city>Hamburg</city>
        <zip>22419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Hagena, Dipl.-Psych.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rumoald Brunner, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelic hospital Ginsterhof HmbH</name>
      <address>
        <city>Rosengarten</city>
        <zip>21224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ute-Christine Haberer, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>October 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Antje Gumz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Anorexia nervosa [MeSH]</keyword>
  <keyword>Feeding and Eating Disorders [MeSH]</keyword>
  <keyword>women</keyword>
  <keyword>youth</keyword>
  <keyword>adolescent</keyword>
  <keyword>duration of untreated illness (DUI)</keyword>
  <keyword>time-to-treatment [MeSH]</keyword>
  <keyword>facilitators</keyword>
  <keyword>barriers</keyword>
  <keyword>factors</keyword>
  <keyword>treatment</keyword>
  <keyword>first treatment initiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
    <mesh_term>Feeding and Eating Disorders of Childhood</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

